Old Web
English
Sign In
Acemap
>
authorDetail
>
Xing Gong
Xing Gong
Hubei University of Medicine
Trametinib
Phosphorylation
MAPK/ERK pathway
Melanoma
Nasopharyngeal carcinoma
1
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
MEK inhibition by trametinib overcomes chemoresistance in preclinical nasopharyngeal carcinoma models.
2021
Anti-Cancer Drugs
Xing Gong
Lei Fan
Pu Wang
Show All
Source
Cite
Save
Citations (0)
1